Robert D Marks, MD in Alabaster, AL - Medicare Gastroenterology

Robert D Marks, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Alabaster, Alabama. He went to Meharry Medical College School Of Medicine and graduated in 1986 and has 38 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice Gastroenterology Associates Of North-central Alabama Inc and his current practice location is 1010 1st St N, Suite 112, Alabaster, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 663-1023.

Robert D Marks is licensed to practice in Alabama (license number 13483) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1972541910.

Contact Information

	Robert D Marks, MD
	1010 1st St N, Suite 112, Alabaster, AL 35007-8608
	(205) 663-1023
	(205) 802-7778

Physician's Profile

Full Name	Robert D Marks
Gender	Male
Speciality	Gastroenterology
Experience	38 Years
Location	1010 1st St N, Alabaster, Alabama
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Robert D Marks attended and graduated from Meharry Medical College School Of Medicine in 1986

NPI Data:

NPI Number: 1972541910
Provider Enumeration Date: 06/03/2006
Last Update Date: 12/04/2007

Medicare PECOS Information:

PECOS PAC ID: 2567440977
Enrollment ID: I20080311000246

Medical Identifiers

Medical identifiers for Robert D Marks such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972541910	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	13483 (Alabama)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Grandview Medical Center	Birmingham, AL	Hospital
Shelby Baptist Medical Center	Alabaster, AL	Hospital
Brookwood Baptist Medical Center	Birmingham, AL	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Gastroenterology Associates Of North-central Alabama Inc	3072591478	77

News Archive

Discovery of compounds that selectively kills cancer stem cells

The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.

Drop in lead exposure may be significant factor behind decrease in crime rates

Exposure to lead in the preschool years significantly increases the chance that children will be suspended or incarcerated during their school careers, according to research at Princeton University and Brown University.

Dyadic International reports $1.1 million net loss for first-quarter 2010

Dyadic International, Inc., a leading-edge biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the quarter ended March 31, 2010.

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845, Abstract 2655).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Robert D Marks allows following entities to bill medicare on his behalf.

Entity Name	Gastroenterology Associates Of North-central Alabama Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1528080595 PECOS PAC ID: 3072591478 Enrollment ID: O20040712001151

News Archive

Discovery of compounds that selectively kills cancer stem cells

Drop in lead exposure may be significant factor behind decrease in crime rates

Dyadic International reports $1.1 million net loss for first-quarter 2010

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert D Marks is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert D Marks, MD 2018 Brookwood Medical Ctr Dr, Suite 206, Birmingham, AL 35209-6898 Ph: (205) 870-0256	Robert D Marks, MD 1010 1st St N, Suite 112, Alabaster, AL 35007-8608 Ph: (205) 663-1023

News Archive

Discovery of compounds that selectively kills cancer stem cells

Drop in lead exposure may be significant factor behind decrease in crime rates

Dyadic International reports $1.1 million net loss for first-quarter 2010

FDA issues health advisory on Levemir insulin

The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market.

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Internal Medicine Doctors in Alabaster, AL

Neeraj Mehta, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112
Nopporn Unnoppet, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1010 1st Street North, Ste 210, Alabaster, AL 35007 Phone: 205-620-8676 Fax: 205-620-8673
Brian Andrew Brunson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 220, Alabaster, AL 35007 Phone: 205-663-1023 Fax: 205-802-7778
Mark Lee Mullens, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112
Clyde Dale Elliott, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112
Dr. James Warren Evans, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1024 1st St N, Alabaster, AL 35007 Phone: 205-664-4051
Bradley A Rubery, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1010 1st St N, Suite 112, Alabaster, AL 35007 Phone: 205-663-1023 Fax: 205-802-7778

Robert D Marks, MD - Medicare Gastroenterology in Alabaster, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Discovery of compounds that selectively kills cancer stem cells

Drop in lead exposure may be significant factor behind decrease in crime rates

Dyadic International reports $1.1 million net loss for first-quarter 2010

FDA issues health advisory on Levemir insulin

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Medicare Reassignments

Discovery of compounds that selectively kills cancer stem cells

Drop in lead exposure may be significant factor behind decrease in crime rates

Dyadic International reports $1.1 million net loss for first-quarter 2010

FDA issues health advisory on Levemir insulin

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Discovery of compounds that selectively kills cancer stem cells

Drop in lead exposure may be significant factor behind decrease in crime rates

Dyadic International reports $1.1 million net loss for first-quarter 2010

FDA issues health advisory on Levemir insulin

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Internal Medicine Doctors in Alabaster, AL